JANUARY 15, 2005
VOLUME 2 NO. 1
 

The cold war on liver cancer

Real-time imaging targets hepatic tumours for cryo-ablation


The only 'ice' most of our livers are familiar with is a cold Vodka Ice or possibly Labatt's Maximum Ice — and we know how 'good' those are for us. However, ice isn't always such a bad thing for livers, especially when it's used to freeze tumours. One of the most promising alternative treatments being developed for liver cancer is to freeze rogue cancer cells by inserting a cryoprobe into the heart of the tumour. But cryo-ablation hasn't been put into practice because it requires very precise targeting that isn't possible without a good visual feed in real time. Fortunately, such William Tell accuracy is now at hand.

A presentation at the Radiological Society of North America's 90th Scientific Assembly and Annual Meeting in Chicago this past December described how magnetic resonance imaging (MRI) literally offers a glimpse of both the successful targeting of the liver tumour and the effectiveness of the cryo-ablation procedure.

ICY STARE
The freezing of a tumour can be followed in real time. "We can actually watch the iceball grow," said presenter Dr Kemel Tuncali of Brigham and Women's Hospital in Boston. "We have better control over the means of killing the tumour with [MRI] and cryotherapy," continued Dr Tuncali. "We can also watch out for critical structures around the area that we don't want to damage, like the bowel, stomach or gall bladder."

In the study, 31 patients aged 29 to 87 who had a total of 44 liver tumours were treated with MRI-guided cryotherapy. Two of the patients had primary liver cancers. The others had cancers that had spread to the liver. The procedure consisted of 15 minutes of quick freezing that was followed by a 10-minute thaw, and then another 15-minute freeze blast.

Of the 44 tumours, 19 were successfully cryozapped. In fact, just a single treatment was found to be effective in 17 of the tumours. Masses smaller than 3.5cm were especially prone to freezing. The success rate of obliterating smaller tumours was 62% while larger tumours naturally had a lower degree of success (49%).

Because the procedure was non-invasive, there was less scarring, recovery was faster and patients got to go home from the hospital sooner. Moreover, the longer-term prognosis following the cryotherapy was good. Overall survival was 77% at 15 months.

SEEING IS BELIEVING
There were some complications of the treatment including a short-term rise in bilirubin, a blood clot in the lung of one patient, clotting and recurrence of a cancerous nodule. But all were treatable and nonlethal.

"The results of a study like this show that treating liver tumours and potentially other tumours with a combination of [magnetic resonance] guidance and cryotherapy has very promising results," according to Dr Tuncali. "Not only does it show local success rates and survival numbers that are encouraging, but it also demonstrates the usefulness of monitoring with [magnetic resonance]."

Dr Reed Omary of Northwestern Memorial Hospital in Chicago described the study results as "promising for lesions that are very difficult to treat." But, according to Dr Omary, the proof of the pudding will require a randomized, controlled study that compares the freezing blast of cryotherapy with the cell cooking approach of radiofrequency.

 

 

back to top of page

 

 

 

 
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T. (514) 995-4398